HALP as a Novel Score for Prediction of Mortality and re_bleeding in Upper GIT Bleeding
Sponsored by Sohag University
About this trial
Last updated 9 months ago
Study ID
Soh-med--25-7-11MS
Status
Not yet recruiting
Type
Observational
Placebo
No
Accepting
18+ Years
All Sexes
Trial Timing
Ended 4 months ago
What is this trial about?
Evaluation of the prognostic utility of the HALP score in patients with upper gastrointestinal bleeding, particularly in predicting re\_bleeding risk and mortality in internal medicine department in Sohag University Hospitals.
What are the participation requirements?
Inclusion Criteria
* Patients will be included if they were initially admitted to the emergency department, had a confirmed diagnosis of upper gastrointestinal bleeding via endoscopy, and were 18 years of age or older.
Exclusion Criteria
* Incomplete clinical data.
* Lack of laboratory results obtained at emergency department admission necessary for the calculation of HALP score; albumin, hemoglobin (HGB), platelets (PLT), or international normalized ratio (INR).
* Pregnancy
* Patients with missing data on clinical outcomes